Taro Pharmaceutical Industries Ltd (NYSE:TARO)

145.59
Delayed Data
As of Apr 24
 -0.71 / -0.49%
Today’s Change
103.33
Today|||52-Week Range
173.00
-1.75%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close146.30
Today’s open145.81
Day’s range144.96 - 147.06
Volume33,101
Average volume (3 months)72,066
Market cap$6.3B
Dividend yield--
Data as of 4:04pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+36.58%
Earnings growth (this year)+30.06%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+13.16%
P/E ratio--
Price/Sales6.47
Price/Book6.17

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc-0.68-1.22%
OPKOPKO Health Inc+0.17+1.16%
ICPTIntercept Pharmaceut...-2.22-0.78%
RCPTReceptos Inc-1.25-0.73%
Data as of 4:04pm ET, 04/24/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$759.3M
Annual profit (last year)$360.4M
Net profit margin47.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Kal Sundaram
Chief Financial &
Accounting Officer, Group VP
Michael Kalb
Corporate headquarters
Haifa Bay, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers